Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB12232KRN-70001 / 2Completed1
DB00563Methotrexate1 / 2Completed1
DB01024Mycophenolic acid1 / 2Completed1
DB00877Sirolimus1 / 2Completed1